Saturday 17 October 2026
Export ICLR’s income statement to Excel — free account
ICON PLC
ICLR Healthcare Diagnostics & Research
ICON PLC’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.76% from fiscal 2024. In the quarter to June 2026, revenue grew 1.20%, EPS fell 59.3%, free cash flow grew 109.7% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years.
170.18
4.95
−2.83%
Follow ICLR
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
6.01% | 2.46% | 1.84% | 0.45% | |
Piotroski F-Score |
5 | 6 | 6 | 6 | |
| 3.41% | 1.39% | 1.05% | 0.26% | ||
ROIC |
3.95% | 2.32% | 2.04% | 1.57% | |
Return on Tangible Assets |
98.98% | 32.71% | 21.07% | 21.23% | |
Average Days of Receivables |
69.88 | 73.10 | 70.93 | 72.65 | |
Free Cash Flow per Share |
12.46 | 10.99 | 9.91 | 11.50 | |
Free Cash Flow |
964.18 | 861.99 | 758.89 | 883.82 | |
Capital Expenditures |
(176.17) | (174.21) | (176.08) | (186.22) | |
| Other line items | |||||
Cash ROIC |
7.30% | 6.51% | 5.64% | 6.45% | |
Accounts Receivable Turnover |
5.15 | 5.14 | 5.26 | 5.21 | |
Accounts Payable Turnover |
52.93 | 33.28 | 56.72 | 59.33 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
7.12 | 11.54 | 5.89 | 6.84 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.02) | (0.09) | (0.13) | (0.61) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
9.35% | 9.45% | 9.46% | 9.30% | |
Share Based Compensation of Revenue |
0.96% | 1.24% | 1.42% | 1.45% | |
Interest Coverage |
3.89 | 2.24 | 1.97 | 1.51 | |
Operating CF/Net income |
1.99 | 4.52 | 5.40 | 25.27 | |
Depreciation/Fixed assets |
0.99 | 0.97 | 0.98 | 0.96 | |
Capex/Depreciation |
(0.45) | (0.45) | (0.47) | (0.50) | |
Revenue per Share |
103.98 | 105.21 | 107.99 | 107.94 | |
Operating CF per Share |
14.74 | 13.21 | 12.21 | 13.92 | |
Capex per Share |
(2.28) | (2.22) | (2.30) | (2.42) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates